Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enanta Pharmaceuticals

5.63
+0.05000.90%
Post-market: 5.630.00000.00%16:00 EDT
Volume:109.74K
Turnover:618.13K
Market Cap:120.10M
PE:-1.14
High:5.80
Open:5.56
Low:5.56
Close:5.58
Loading ...
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 07, 2023

Major Issues Report

8-K - Current report
Feb 06, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 23, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 21, 2022

Major Issues Report

8-K - Current report
Aug 26, 2022

Major Issues Report

8-K - Current report
Aug 08, 2022

Major Issues Report

8-K - Current report
Aug 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 22, 2022

Major Issues Report

8-K - Current report
May 17, 2022

Major Issues Report

8-K - Current report
May 09, 2022

Major Issues Report

8-K - Current report
May 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 09, 2022

Major Issues Report

8-K - Current report
Mar 08, 2022

Major Issues Report

8-K - Current report
Feb 15, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 15, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals